These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18322766)

  • 21. Generic Drugs - Decreasing Costs and Room for Increased Number of Kidney Transplantations.
    Spasovski G
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):133-8. PubMed ID: 27442379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing bioequivalence and drug interchangeability.
    Chen M; Chow SC
    J Biopharm Stat; 2017; 27(2):272-281. PubMed ID: 27936343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Generic drugs].
    Delporte JP
    Rev Med Liege; 2002 Jan; 57(1):13-22. PubMed ID: 11899492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bioequivalence and generics of index drugs with narrow therapeutic margins].
    Le Corre P
    Presse Med; 2010 Feb; 39(2):169-76. PubMed ID: 19932591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of the European Medicines Agency's Development of Product-Specific Bioequivalence Guidelines.
    Sullivan JO; Blake K; Berntgen M; Salmonson T; Welink J;
    Clin Pharmacol Ther; 2018 Sep; 104(3):539-545. PubMed ID: 29319156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality].
    Carrillo Norte JA; Postigo Mota S
    Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some thoughts on drug interchangeability.
    Chow SC; Song F; Chen M
    J Biopharm Stat; 2016; 26(1):178-86. PubMed ID: 26366703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A European perspective on orally inhaled products: in vitro requirements for a biowaiver.
    García-Arieta A
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):419-29. PubMed ID: 25238116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring community pharmacists' views on generic medicines: a nationwide study from Malaysia.
    Chong CP; Hassali MA; Bahari MB; Shafie AA
    Int J Clin Pharm; 2011 Feb; 33(1):124-31. PubMed ID: 21365404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A series of N-of-1 trials to assess the therapeutic interchangeability of two enalapril formulations in the treatment of hypertension in Addis Ababa, Ethiopia: study protocol for a randomized controlled trial.
    Alemayehu C; Mitchell G; Aseffa A; Clavarino A; McGree J; Nikles J
    Trials; 2017 Oct; 18(1):470. PubMed ID: 29017595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interchangeability of generic drugs for subpopulations: Bioequivalence simulation from a nonparametric PK model of gabapentin generic drugs.
    Glerum PJ; Yamada WM; Neely MN; Burger DM; Maliepaard M; Neef C
    Br J Clin Pharmacol; 2024 Jul; 90(7):1576-1585. PubMed ID: 36482842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory and clinical aspects of psychotropic medicinal products bioequivalence.
    Bałkowiec-Iskra E; Cessak G; Kuzawińska O; Sejbuk-Rozbicka K; Rokita K; Mirowska-Guzel D
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1027-34. PubMed ID: 25858104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®.
    Gasser UE; Fischer A; Timmermans JP; Arnet I
    BMC Pharmacol Toxicol; 2013 Apr; 14():24. PubMed ID: 23617953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory Considerations of Bioequivalence Studies for Oral Solid Dosage Forms in Japan.
    Kuribayashi R; Takishita T; Mikami K
    J Pharm Sci; 2016 Aug; 105(8):2270-7. PubMed ID: 27372551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic drugs for the treatment of ocular conditions: changing the treatment landscape.
    Aref AA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):551-3. PubMed ID: 24957466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology.
    Lechat P
    Eur J Drug Metab Pharmacokinet; 2022 Nov; 47(6):777-787. PubMed ID: 35986193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical and regulatory considerations in assessments of interchangeability of biological drug products.
    Tóthfalusi L; Endrényi L; Chow SC
    Eur J Health Econ; 2014 May; 15 Suppl 1(Suppl 1):S5-11. PubMed ID: 24832831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global Harmonization of Comparator Products for Bioequivalence Studies.
    Gwaza L; Gordon J; Leufkens H; Stahl M; García-Arieta A
    AAPS J; 2017 May; 19(3):603-606. PubMed ID: 28265983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.